|
Lucid Diagnostics Inc (NASDAQ: LUCD) |
|
Lucid Diagnostics Inc
LUCD's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Lucid Diagnostics Inc growth rates, revenue grew
by 49.68 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 519
Medical Equipment & Supplies industry recorded
growth of revenues by 1.72 %
Lucid Diagnostics Inc net loss decreased from $-14 millions, to $-12 millions in III. Quarter 2024,
• More on LUCD's Growth
|
|
Lucid Diagnostics Inc realized a net loss in trailing twelve months.
Lucid Diagnostics Inc realized cash reduction of $ -0.19 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 9.82.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.32.
• More on LUCD's Valuation
|
|
|
|
|
Lucid Diagnostics Inc realized net loss in trailing twelve months.
Lucid Diagnostics Inc realized cash outflow of $ -0.19per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 9.82.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.32.
Lucid Diagnostics Inc Price to Book Ratio is at 6.49 higher than Industry Avg. of -953.45, and higher than S&P 500 Avg. of 0.01
• More on LUCD's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com